Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1989 2
1990 2
1992 1
1993 4
1995 3
1996 1
1997 6
1998 2
1999 4
2000 2
2002 1
2003 3
2004 1
2005 3
2006 1
2007 2
2008 3
2009 4
2010 4
2011 6
2012 9
2013 10
2014 9
2015 8
2016 5
2017 3
2019 1
2020 1
2022 2
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

92 results

Results by year

Filters applied: . Clear all
Page 1
Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial.
Fangusaro J, Onar-Thomas A, Young Poussaint T, Wu S, Ligon AH, Lindeman N, Banerjee A, Packer RJ, Kilburn LB, Goldman S, Pollack IF, Qaddoumi I, Jakacki RI, Fisher PG, Dhall G, Baxter P, Kreissman SG, Stewart CF, Jones DTW, Pfister SM, Vezina G, Stern JS, Panigrahy A, Patay Z, Tamrazi B, Jones JY, Haque SS, Enterline DS, Cha S, Fisher MJ, Doyle LA, Smith M, Dunkel IJ, Fouladi M. Fangusaro J, et al. Among authors: jakacki ri. Lancet Oncol. 2019 Jul;20(7):1011-1022. doi: 10.1016/S1470-2045(19)30277-3. Epub 2019 May 28. Lancet Oncol. 2019. PMID: 31151904 Free PMC article. Clinical Trial.
Phase 2 study of concurrent radiotherapy and temozolomide followed by temozolomide and lomustine in the treatment of children with high-grade glioma: a report of the Children's Oncology Group ACNS0423 study.
Jakacki RI, Cohen KJ, Buxton A, Krailo MD, Burger PC, Rosenblum MK, Brat DJ, Hamilton RL, Eckel SP, Zhou T, Lavey RS, Pollack IF. Jakacki RI, et al. Neuro Oncol. 2016 Oct;18(10):1442-50. doi: 10.1093/neuonc/now038. Epub 2016 Mar 22. Neuro Oncol. 2016. PMID: 27006176 Free PMC article. Clinical Trial.
Ependymomas: development of immunotherapeutic strategies.
Pollack IF, Jakacki RI, Butterfield LH, Okada H. Pollack IF, et al. Among authors: jakacki ri. Expert Rev Neurother. 2013 Oct;13(10):1089-98. doi: 10.1586/14737175.2013.840420. Expert Rev Neurother. 2013. PMID: 24117271 Free PMC article. Review.
Peptide vaccine therapy for childhood gliomas.
Pollack IF, Jakacki RI, Butterfield LH, Okada H. Pollack IF, et al. Among authors: jakacki ri. Neurosurgery. 2013 Aug;60 Suppl 1:113-9. doi: 10.1227/01.neu.0000430769.33467.68. Neurosurgery. 2013. PMID: 23839362 Review. No abstract available.
Implementation of mechanism of action biology-driven early drug development for children with cancer.
Pearson AD, Herold R, Rousseau R, Copland C, Bradley-Garelik B, Binner D, Capdeville R, Caron H, Carleer J, Chesler L, Geoerger B, Kearns P, Marshall LV, Pfister SM, Schleiermacher G, Skolnik J, Spadoni C, Sterba J, van den Berg H, Uttenreuther-Fischer M, Witt O, Norga K, Vassal G; Members of Working Group 1 of the Paediatric Platform of ACCELERATE. Pearson AD, et al. Eur J Cancer. 2016 Jul;62:124-31. doi: 10.1016/j.ejca.2016.04.001. Epub 2016 May 31. Eur J Cancer. 2016. PMID: 27258969 Review.
Chondrosarcoma.
Jakacki R, Knisely A. Jakacki R, et al. Med Pediatr Oncol. 1990;18(1):61-3. doi: 10.1002/mpo.2950180113. Med Pediatr Oncol. 1990. PMID: 2294392 No abstract available.
92 results